Podcasts about Public health

About this episode: The reconciliation bill passed by Congress in July is set to unravel key aspects of the Affordable Care Act that have expanded health coverage to millions of Americans. In this episode: One of the architects of the ACA, Liz Fowler, outlines how work requirements, truncated enrollment periods, and higher premiums will change health care for Americans on Medicaid and Medicare and for those buying coverage through their state's marketplace. Guest: Elizabeth Fowler, PhD, JD, is a distinguished scholar in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health and previously served as the director of the Innovation Center at the Centers for Medicare & Medicaid Services. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: How New Federal Legislation Will Affect Health Care Costs and Access for Americans—Johns Hopkins Bloomberg School of Public Health When Do the One Big Beautiful Bill Act's Health Care Provisions Go Into Effect?—Center for American Progress Health Provisions in the 2025 Federal Budget Reconciliation Law—KFF Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Standing on stage with nothing but a microphone, Sara Pascoe knows instantly if she's succeeded or failed. Comedy doesn't let you hide, if the joke doesn't land, the silence tells you.But what makes Sara remarkable isn't just her success as a writer, actor, and stand-up. It's the habit she's built to handle failure and keep showing up: Unconditional Positive Regard. The belief that your worth isn't defined by a single mistake, a bad night, or a difficult moment.In this episode, I share what I learned from Sara about how self-compassion fuels resilience. She shows us why the way we talk to ourselves matters more than the outcome, and how reframing failure can turn doubt into progress.Together, we explore:Why comedians face some of the toughest performance pressureHow to separate who you are from what you doThe psychology of Unconditional Positive RegardHow self-compassion creates lasting confidenceIf you've ever been too hard on yourself after falling short, this episode is a reminder that high performance isn't about being flawless. It's about having the courage to try again, and the kindness to believe in yourself when you do.Here is more information on the studies referenced: The necessary and sufficient conditions of therapeutic personality change. Journal of Consulting Psychology (Rogers, C. R. 1957)Perceived Coach Empathy and Athlete Outcomes International Journal of Environmental Research and Public Health (2023)Alex Shevrin: Unconditional Positive Regard Video, Massachusetts Teachers Association.Bringing Carl Rogers Back In: Exploring the Power of Positive Regard at Work, British Journal of Management, 2018Listen to the full episode with Sara Pascoe: https://pod.fo/e/2b7c84 Hosted on Acast. See acast.com/privacy for more information.

The effects of the neurotoxin are taking their toll on Cooper as Shannon desperately tries to navigate the severity of their new reality.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper Burkett.E43 features Jenny Maguire, JD Mollison, Laith Nakli, Deirdre O'Connell, Carolyn Baeumler, Zach Shaffer, and Monique Woodley. Casting by Alaine Alldaffer and Lisa Donadio. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

About this episode:  Sickle cell disease affects an estimated 100,000 people in the United States. Recent advancements in gene therapies and medicines like hydroxyurea are diminishing extreme pain, reducing strokes, and extending survival times for those afflicted by the disease. In this episode: leading sickle cell disease expert Dr. Mark Gladwin explains how revolutionary new treatments work and discusses the challenges to access to life-saving care. Guest: Dr. Mark Gladwin is a physician-scientist and the Dean of the University of Maryland School of Medicine and Vice President for Medical Affairs at the University of Maryland, Baltimore. His research focuses include sickle cell disease and hypertension. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle—CNBC Gene Therapy: What You Need to Know—Sickle Cell Disease Association of American No More Pain: Breakthrough Sickle Cell Treatment from Johns Hopkins Offers Curative Potential—Johns Hopkins School of Medicine Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

One in four Americans is enrolled in Medicaid, yet the system designed to support them is constantly at risk—underfunded, politically vulnerable, and often overlooked.Dr. Alastair Bell, President and CEO of Boston Medical Center Health System, shares how his organization is reimagining what it means to care for underserved populations, while managing nearly 40% of Massachusetts' Medicaid enrollees. In this conversation, we explore the financial realities of running an “essential” hospital system, the opportunities and pitfalls of Medicaid ACOs, and why AI might deepen inequity if essential providers are left behind.We cover:

Mercy Kafotokoza is a Malawian nurse, midwife and public health professional with a Master's in Public Health. She is also a mother of three and a passionate advocate for equity, compassion and the power of proximity. As a young girl, Mercy experienced the heartbreak of losing her uncle to a preventable condition. She is now the founder of Wandikweza, a community-led organization delivering health with dignity directly to people's doorsteps. At Wandikweza, no community is too remote to get help, and her strength touches me from across the world. We discuss Mercy's journey of service, her strategic partnerships that foster trust in nurses, and the obstacles that she has faced as a woman in a leadership position. Today's episode was produced by Tani Levitt and Mijon Zulu. To check out more episodes or to learn more about the show, you can visit our website Allaboutchangepodcast.com. If you like our show, spread the word, tell a friend or family member, or leave us a review on your favorite podcasting app. We really appreciate it. All About Change is produced by the Ruderman Family Foundation. Episode Chapters 0:00 Intro 1:17 Personal loss shaped Mercy's career choices 4:04 The state of healthcare in Malawi 9:13 Bringing healthcare to the people 11:10 Community health workers and nurses on bikes 17:05 Women's health and female empowerment 22:04 What inspires Mercy 25:40 Goodbye and outro For video episodes, watch on www.youtube.com/@therudermanfamilyfoundation Stay in touch: X: @JayRuderman | @RudermanFdn LinkedIn: Jay Ruderman | Ruderman Family Foundation Instagram: All About Change Podcast | Ruderman Family FoundationTo learn more about the podcast, visit https://allaboutchangepodcast.com/ Looking for more insights into the world of activism? Be sure to check out Jay's brand new book, Find Your Fight, in which Jay teaches the next generation of activists and advocates how to step up and bring about lasting change. You can find Find Your Fight wherever you buy your books, and you can learn more about it at ⁠⁠⁠⁠⁠⁠www.jayruderman.com⁠⁠⁠⁠⁠⁠.

New Zealand's youth vaping rates are among the highest in the world. How did we get here and what will this mean for the future of our rangatahi? A 2018 court case paved the way for a loose regulatory start for vaping in New Zealand, and rapid uptake by those aged 14–24 in the years since has led to concerns that a new generation is now addicted to nicotine. New Zealand researchers are investigating how vaping affects our lungs, and the harms young people are experiencing in terms of social connections and mental health. Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.Guests:Dr Lucy Hardie, School of Population Health, University of AucklandDr Kelly Burrowes, Auckland Bioengineering Institute, University of AucklandMarizeh Aghababaie, Auckland Bioengineering Institute, University of AucklandLani Teddy, Department of Public Health, University of OtagoLearn more:Check out the map mentioned in this episode, which, as well as the school data, also includes an investigation into the overlap of vape store density and area-level deprivation. Lucy and her colleagues have recently written a piece for The Conversation about how vape companies are using global social media accounts to skirt marketing regulations.There are currently no dedicated vaping cessation supports, but a clinical trial is being run to investigate developing one.University of Otago's Professor Janet Hoek spoke to Nine to Noon about the new vaping laws that came into effect in June 2025.References:…Go to this episode on rnz.co.nz for more details

Bruce Gellin, MD, MPH, FIDSA, ID physician and senior advisor at the Georgetown University Global Health Institute, joins Buddy Creech, MD, MPH, FPIDS, to discuss the Vaccine Integrity Project and the importance of ensuring vaccine policy remains grounded in evidence. The two explore strategies for countering misinformation, building public trust, and empowering health care professionals to engage in constructive conversations about immunization.Shape the future of ID with peers from around the world this October at IDWeek in Atlanta, Georgia! Register today ➡️ https://registration.experientevent.com/ShowIDS251View the interactive program ➡️ https://idweek2025.eventscribe.net/

About this episode: Fall vaccines for flu, RSV, and—more recently—COVID have long followed a uniform rollout schedule allowing clinics and pharmacies ample time to order and administer shots. But that process looks different this year, raising concerns about access. In this episode: Katelyn Jetelina, publisher of Your Local Epidemiologist, explains how changes to the CDC's Advisory Committee on Immunization Practices (ACIP) and the FDA are pushing back the timeline and changing recommendations for routine vaccinations. Guest: Katelyn Jetelina, PhD, MPH, is an epidemiologist and scientific communicator. She is the co-founder of Health Trust Initiative, an adjunct professor at Yale School of Public Health, and a Senior Scientific Advisor to several government and non-profit agencies, including the CDC. In addition, Jetelina is the publisher of Your Local Epidemiologist. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: What's the plan for fall vaccines? If you're confused, you're not alone—Your Local Epidemiologist Covid cases rising in US as officials plan to restrict booster vaccines—The Guardian Will New Vaccine Recommendations Affect Your Fall Flu Shot?—AARP Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

 It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: cancer reserach may lead to T1D treatment, GLP-1 oral pill moves forward, Tandem pharmacy moves, Medtronic-Abbott sensor unveield, parents of kids with T1D see income drop, Mannkind submits Afrezza for pediatrics, diabetes scholarships and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Cornell researchers have developed an implant system that can treat type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for immunosuppression. The system could also potentially provide long-term treatment for a range of chronic diseases. This lab has produced previous implantable devices that have proved effective in controlling blood sugar in diabetic mice, but they can only last so long. "It's the proof of concept. We really proved that oxygenation is important, and oxygenation will support high cell-density capsules," Tempelman said. "The capsules are immune protective and last for a long time without having some kind of fouling of the membrane. The body never likes it when you put a foreign substance in. So that's the engineering in the Ma Lab, to look for materials and coatings for the materials that are immune protective, but also don't invoke excess response from the body because of the material." The next step will be to implant the system in a pig model, and also test it with human stem cells. The researchers are interested in eventually trying to use the system for implanting different cell types in humans for long-term treatment of chronic diseases, according to Tempelman, who is CEO of Persista Bio Inc., a new startup she founded with Ma and Flanders that is licensing these technologies. https://medicalxpress.com/news/2025-08-implant-diabetes-oxygenating-insulin-cells.html XX Mayo Clinic cancer research may be big news for T1D. After identifying a sugar molecule that cancer cells use on their surfaces to hide from the immune system, the researchers have found the same molecule may eventually help in the treatment of type 1. Cancer cells use a variety of methods to evade immune response, including coating themselves in a sugar molecule known as sialic acid. The researchers found in a preclinical model of type 1 diabetes that it's possible to dress up beta cells with the same sugar molecule, enabling the immune system to tolerate the cells. The findings show that it's possible to engineer beta cells that do not prompt an immune response   In the preclinical models, the team found that the engineered cells were 90% effective in preventing the development of type 1 diabetes. The beta cells that are typically destroyed by the immune system in type 1 diabetes were preserved.     https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-sugar-coating-cells-can-protect-those-typically-destroyed-in-type-1-diabetes/ XX A daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.   The drug, orforglipron, is a GLP-1, a class of drugs that have become blockbusters because of their weight-loss effects. But the GLP-1s on the market now are expensive, must be kept refrigerated and must be injected. A pill that produces similar results has the potential to become far more widely used, though it is also expected to be expensive.   Lilly said it would seek approval from the Food and Drug Administration later this year to market orforglipron for obesity and early in 2026 for diabetes. https://www.nytimes.com/2025/04/17/health/pill-glp-1-eli-lilly.html XX Use of diabetes technology has dramatically increased and glycemic control has improved among people with type 1 diabetes (T1D) in the US over the past 15 years, but at the same time, overall achievement of an A1c level < 7% remains low and socioeconomic and racial disparities have widened. These findings came from an analysis of national electronic health records of nearly 200,000 children and adults with T1D by Michael Fang, PhD, of the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues. The study was published online on August 11, 2025, in JAMA Network Open. Use of continuous glucose monitors (CGMs) increased substantially from 2009-2011 to 2021-2023, from less than 5% in both children and adults to more than 80% and over half, respectively. While A1c levels did drop over the 15 years, just 1 in 5 children and slightly over a quarter of adults achieved a level < 7%. The average A1c level stayed above 8%, with ethnic minorities and low-income patients seeing the smallest gains.       https://www.medscape.com/viewarticle/diabetes-tech-use-rise-a1c-reductions-still-lag-2025a1000lc9 XX Inflammation may predict how well people with diabetes respond to depression treatment, and the effects differ dramatically between type 1 and type 2 diabetes. Diabetes and depression often appear together. Indeed, depression is more than three times more prevalent in people with type 1 diabetes (T1D) and nearly twice as prevalent in people with type 2 diabetes (T2D). When they appear together, treatment for depression can vary widely. In a new study, researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (FIDAM), and the German Center for Diabetes Research (DZD) investigated how inflammation in the body relates to improvement in depression symptoms in people with T1D and T2D. The researchers combined data from three previous German randomized clinical trials that aimed to reduce elevated depressive symptoms and diabetes distress in people with type 1 or type 2 diabetes. Diabetes distress is characterized by feelings of overwhelm, frustration, guilt and worry about diabetes management and its potential complications. A total of 332 participants with T1D and 189 with T2D who had completed both a baseline and 12-month follow-up examination were included in the present study. Measures included depression using the Center for Epidemiological Studies Depression scale (CES-D), blood tests for 76 inflammatory biomarkers, and symptoms broken down into cognitive-affective (e.g., feeling hopeless), somatic (e.g., poor sleep, fatigue), and anhedonia (loss of pleasure) clusters.   After adjusting for factors like age, body mass index (BMI), diabetes duration, cholesterol, and co-existing illnesses, the researchers found that in patients with T1D, higher baseline inflammation was linked to smaller improvements in depression. Inflammation seemed to be more connected to physical/somatic symptoms in T1D patients. In those with T2D, higher baseline inflammation was linked to greater improvements in depression. For these patients, the effect was strongest for cognitive-affective and anhedonia – so, emotional and motivational – symptoms.   The researchers weren't sure what caused the difference between T1D and T2D, but they suggest it might be due to the different forms of immune activation seen in each condition. That is, autoimmune processes in type 1 and metabolic inflammation in type 2. https://newatlas.com/health-wellbeing/inflammation-diabetes-depression-treatment/ XX Parents of children diagnosed with type 1 diabetes suffer an income drop in the years following the diagnosis. The impact is more pronounced in mothers, especially mothers of children diagnosed in preschool years. And these findings come from a European study.. not the US. Previous research has shown that parents of children with type 1 diabetes are at increased risk of stress-related symptoms and may need to reduce their working hours. "In our study, we observed reduced parental work-related incomes in the years following the child's type 1 diabetes diagnosis. The drop was larger in mothers than in fathers. Since mothers earned significantly less than fathers in absolute terms, even before the child fell ill, the relative drop in mothers was 6.6% the year following diagnosis compared to 1.5% in fathers. We further note the greatest impact on work-related incomes in mothers of children diagnosed at preschool age," says Beatrice Kennedy, physician at the Endocrine and Diabetes unit at Uppsala University Hospital and Associate Professor of Medical Epidemiology at Uppsala University, who led the study. This is a huge study, builds on data from national population and health registers and the Swedish Child Diabetes Register (Swediabkids). The study includes the parents of more than 13,000 children diagnosed with type 1 diabetes in Sweden in 1993−2014, as well as more than half a million parents in the general population who have children not diagnosed with diabetes.   The researchers observed that the maternal pension-qualifying incomes (a composite outcome including work-related income and societal benefits) initially increased after the child's diagnosis. This was attributable to mothers applying for the parental care allowance from the Swedish Social Insurance Agency. The parental care allowance was intended to compensate for disease-related loss of work-related income and contribute toward disease-specific costs.   When the research team investigated long-term effects in mothers, they found that the pension-qualifying incomes gradually decreased after eight years, and had not recovered by the end of follow-up − 17 years after the children were diagnosed. https://www.news-medical.net/news/20250811/Mothers-face-greater-financial-impact-following-childe28099s-type-1-diabetes-diagnosis.aspx XX The U.S. Department of Justice has reached a settlement with Metro Nashville Public Schools after allegations that the district violated the Americans with Disabilities Act.   The parents of a student at the Ross Early Learning Center requested that the school monitor their child's glucose monitor. Investigators found the school refused to do so, despite the child's Type 1 Diabetes diagnosis.   As part of the settlement, MNPS agreed to change its policies to allow the use of these devices, ensure trained staff can monitor them throughout the entire school day and at school activities, and improve communication with parents. https://www.wsmv.com/2025/08/12/metro-nashville-public-schools-settles-allegations-it-discriminated-against-students-with-diabetes/ XX Modular Medical has unveiled Pivot, its next-generation insulin patch pump technology aimed at simplifying diabetes care. The company announced its new pump for “almost-pumpers” at the Association of Diabetes Care & Education Specialists (“ADCES”) Conference in Phoenix, Arizona this weekend. It aims for Pivot to target adults with a user-friendly, affordable design.   Modular Medical's current pump, the MODD1, won FDA clearance nearly a year ago. It features new microfluidics technology to allow for the low-cost pumping of insulin. The system has a reservoir size of 300 units/3mL. Users can monitor the pump activity with their cell phone and do not require an external controller. The pump uses a provided, single-use, disposable battery.   The company announced recently that it validated its insulin pump cartridge line for human-use production in the U.S. Days later, it reported the first human use of the MODD1 pump.   Now, it has taken the next steps with the debut of a next-gen pump, set for FDA submission in October.   Modular Medical also gamifies diabetes care The company also said ADCES is the place where it will showcase the first playable level of its new Pivot pump gamified trainin module. Level Ex, a developer of medical games, develops the module.   Modular Medical said gamification offers a way to make medical training more effective and efficient while improving information retention. Given the complexity in pump uptake, the company hopes to provide an easy way to bring its technology to clinicians and patients.   The company expects to have training modules available at the same time as the pump's planned launch in 2026.   “Level One is free because diabetes mastery shouldn't come with a price tag,” Sam Glassenberg, CEO of Level Ex, said. “Modular Medical is breaking barriers too – bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive.   “People learn best through play – and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay – they're asking to ‘play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible.” https://www.drugdeliverybusiness.com/modular-medical-unveils-next-gen-insulin-pump/ XX On Tuesday, 12 August 2025, Tandem Diabetes Care (NASDAQ:TNDM) presented at the Canaccord Genuity's 45th Annual Growth Conference, outlining strategic shifts and market focus. The company highlighted its plans for commercial transformation in the U.S. and expansion in international markets, alongside addressing competitive challenges and regulatory impacts. While optimistic about growth in Outside the U.S. (OUS) markets, Tandem is navigating a more competitive landscape domestically. We have entered into the pharmacy channel with Mobi only. And so as Mobi's been building up volume, we're getting experience and we're really learning and understanding what pharmacy offers to us. And the proof points have proved out the thesis I said earlier, which is it can really reduce that barrier for patients, is the out of pocket cost. And so we've decided to accelerate our strategy and where we were starting just with Mobi, we are now moving t slim supplies into the pharmacy channel, and that will kick into gear in the fourth quarter. So as people are looking at the cadence of sales for the remainder of the year with this reframing, many folks are seeing what looks like a a might be an outsized fourth quarter and and having trouble understanding those dynamics. We'll be adding the tSIM supplies to those contracts. We also have more coverage. We will have it in the coming weeks effective this year, so we will be increasing that 30% rate before the end of the year. And then, obviously, everyone's in the same cycle right now already negotiating and discussing their 2026 coverage. And so 30% is the floor.   We do expect to continue to grow that coverage in the coming years, and ultimately have a much broader access. Absolutely. It's an exciting technology that allows for us to have an infusion set that extends the wear time from three days to up to seven days. So we're able to use that as part of an independent infusion set, which would then be used with the t slim and with the mobi pump today. But we're also using that same technology as part of the site that's used for mobi when you use it with a tubeless cartridge. So next year, we will launch Mobi in a patch configuration.   It uses the same pump that's available today, but by using a modified cartridge, you're able to wear it as a patch pump. So one of the things we announced on the call is that we're using this extended wear technology as part of that site. So what it allows you to do is to change the portion that you wear in your skin separate from the timing of when you change the insulin cartridge. So it allows for that extended wear time, reduction of burden to the patient, which is especially important for higher volume insulin users as we expand into type two. So from here, we will launch the extended wear site next year along with we'll do a separate regulatory filing for the cartridge portion for Mobi that includes this extended wear technology as a predicate device. So that's another filing that we'll need to do, but we have the clearance today for the independent infusion set, but we'll file another five ten k for use of the extended wear technology as part of the tubeless Mobi feature. https://za.investing.com/news/transcripts/tandem-diabetes-at-canaccord-conference-strategic-shifts-and-market-focus-93CH-3834464 XX MannKind today announced a significant regulatory submission and a large financing agreement with Blackstone. The company submitted its lead inhaled insulin product for expanded FDA approval and secured $500 million in funding, it said.   First, the Danbury, Connecticut-based company announced that it submitted a supplemental Biologics License Application (sBLA) for Afrezza, its inhaled insulin product, in the pediatric population.   MannKind Director of Medical and Scientific Engagement Joanne Rinker, MS, RDN, BC-ADM, CDCES, LDN, FADCES, told Drug Delivery Business News at ADA 2025 that a submission was on the way for children and adolescents aged 4-17 years old. Further data shared at ADA found Afrezza both safe and effective in that age range.   Afrezza is a fast-acting insulin formulation delivered through an inhaler device. MannKind engineered the mechanical inhaler device to slowly bring powder into the lung. A small compartment opens for the insertion of the insulin cartridge, then the user closes it. The only other component is a mouthpiece for the sake of cleanliness. Then, the inhalation takes just two seconds. It requires no electronics or extra components.   The company expects a review acceptance decision early in the fourth quarter of 2025.   “The submission of our supplemental Biologics License Application (sBLA) for Afrezza in pediatric patients is a meaningful milestone for MannKind and people living with diabetes,” said Michael Castagna, CEO of MannKind Corporation.   Additional funding provides a significant boost for MannKind MannKind also announced a strategic financing agreement with funds managed by Blackstone worth up to $500 million. The financing provides MannKind with non-dilutive capital to advance its short- and long-term growth strategies.   This senior secured credit facility includes a $75 million initial term loan funded at closing. It then has a $125 million delayed draw term loan available for the next 24 months. Finally, it features an additional $300 million uncommitted delayed draw term loan available at the mutual consent of MannKind and Blackstone.   The facility bears interest at a calculated SOFR variable rate plus 4.75% and matures in August 2030.   “This strategic financing significantly increases our operating flexibility and provides us substantial access to non-dilutive capital on favorable terms, complementing our strong cash position,” said Castagna. “The funding will support the expansion of our commercial team in preparation for the anticipated launch of the pediatric indication for Afrezza, if approved, continued pipeline advancement, potential business development opportunities, and general corporate purposes. Partnering with the Blackstone team on this transaction positions us to accelerate our next phase of growth and innovation.” https://www.drugdeliverybusiness.com/mannkind-fda-submission-pediatrics-500m-blackstone/ XX   Medtronic MiniMed Abbott Instinct Sensor [Image from Medtronic Diabetes on LinkedIn] The Medtronic Diabetes business today took to social media to share an early preview of a new integrated Abbott sensor for its insulin delivery systems. Medtronic Diabetes — soon to be MiniMed after its planned separation from the medtech giant – said in the post that the new sensor specifically designed for its own systems is called “Instinct.”   “Get a sneak peek at what's coming next: the Instinct sensor,” the business unit's account wrote. “Made by Abbott, the Instinct sensor is designed exclusively for MiniMed systems. We'll share more details about the Instinct sensor when it's commercially available.”   The sensor, built on the Abbott FreeStyle Libre platform, reflects “the power of the partnership,” Abbott EVP, Diabetes Care, Chris Scoggins, told Drug Delivery Business News earlier this year.   Medtronic and Abbott — two of the largest diabetes tech companies in the world — announced a year ago that they entered into a global partnership pairing Abbott continuous glucose monitors (CGMs) with Medtronic insulin delivery systems.   The partnership aims to collaborate on a system based on Abbott's FreeStyle Libre CGMs with Medtronic's automated insulin delivery technology (the latest generation being the MiniMed 780G) and smart insulin pen systems, such as the InPen system.   Read more about Medtronic, Abbott and the rest of the diabetes tech industry in our free Diabetes Technology Special Report. Medtronic's systems previously used its own CGMs, such as the Guardian 4 and the Simplera platform, and the company intends to continue using those systems as part of a comprehensive CGM portfolio. Under the companies' agreement, the systems would be sold exclusively by Medtronic — including the Abbott CGM.   The companies brought the partnership a step further in April when Medtronic announced the submission of an interoperable pump with the Abbott sensor technology to the FDA. They plan to share more details following the expected FDA clearance, which remains pending.   Management also recently emphasized the multi-year nature of the partnership, meaning Medtronic could pair current and future pumps with other Abbott sensors in the future. That could hint at integration with the company's future dual glucose-ketone monitor, as a number of pump makers have already announced collaborations to pair their systems with the sensor once it hits the market. https://www.drugdeliverybusiness.com/medtronic-diabetes-previews-abbott-sensor-minimed/ XX Governor Glenn Youngkin joined Civica officials at the company's Petersburg manufacturing facility to announce a $3 million grant from the Commonwealth of Virginia to accelerate Civica's efforts to develop and produce affordable insulin for Americans living with diabetes.   CivicaRx Logo   "We are proud to partner with Civica in their mission to make essential medicines more accessible," said Governor Youngkin. "This investment reflects our belief in the power of public-private collaboration to improve lives and strengthen communities."   These funds will support the production of insulin aspart, a rapid-acting human insulin analog used to regulate blood sugar in adults and children with diabetes. Civica plans to produce both rapid- and long-acting insulins at its state-of-the-art manufacturing facility in Petersburg, Va., where the company now employs more than 200 skilled workers.1 Over 8 million people living with diabetes need rapid-acting and/or long-acting insulin.   The Governor also announced that he had officially proclaimed August 7 – 14 2025 'Life Sciences Week' demonstrating the Commonwealth's commitment to "accelerating the advancement of the life sciences through public-private partnerships, STEM education, workforce development, and sustained investment in research and development."   "We are grateful for the Commonwealth's support," said Ned McCoy, Civica's President and CEO. "This funding will help us move closer toward our goal of ensuring that no one has to choose between insulin and other basic needs."   Civica and Virginia officials were joined by Lynn Starr, Chief Global Advocacy Officer of Breakthrough T1D, the leading global type 1 diabetes research and advocacy organization.   "More than one million American adults live with type 1 diabetes, and many still, sadly, ration their insulin, due to the prohibitively high cost of this necessary medication," said Starr.  "Civica's work will help to make insulin more affordable for people across the country."   Breakthrough T1D is among more than two dozen organizations and philanthropists, along with the states of Virginia and California, that have partnered with Civica to support the development of affordable insulins.   Civica's insulin initiative aims to provide patients with predictable, transparent pricing — no more than $30 per vial or $55 for a box of five pens — regardless of insurance status.   About Civica Civica is a nonprofit pharmaceutical company established to address drug shortages. It was founded by a group of U.S. health systems and philanthropies who, after more than a decade of chronic shortages, recognized that the market was not self-correcting and that a different approach is required. Civica works to deliver a safe, stable, and affordable supply of essential medicines to U.S. patients.   Media Contact: Liz Power liz.power@civicarx.org +1 860 501 3849 https://cbs4indy.com/business/press-releases/cision/20250807NY46213/governor-glenn-youngkin-announces-3-million-grant-to-support-civicas-affordable-insulin-programs/ XX If you or someone you love is living with diabetes, you already know the fight isn't just medical—it's financial, too. Between daily supplies, doctor visits, and long-term care, the cost of managing type 1 or type 2 diabetes can be overwhelming. Add college or trade school into the equation, and suddenly staying healthy competes with building a future. That's where scholarships for students with diabetes—like Beyond Scholars and others listed here—step in.   Whether you're headed to a university, a two-year college, or a hands-on trade program, these opportunities were created to ease the load.   Scholarships for students with diabetes Beyond Scholars (from Beyond Type 1): $10,000 for recently graduated high school seniors with type 1 diabetes or type 2 diabetes entering college or trade school. This is one of the largest needs-based diabetes scholarships in the United States. This year, awardees will also receive 6 months of wellness coaching through Risely Health.   Applications open: July 25, 2025 Deadline: August 29, 2025 Winners announced: October 2025 https://beyondtype1.org/beyond-scholars-diabetes-scholarships-college-trade-school/ XX Nick Jonas and Kyle Rudolph are using their platforms for a good cause.   On Tuesday, Aug. 12, the singer and the former NFL tight end (via his professional fundraising platform Alltroo) announced they're teaming up to launch a rally featuring a fan-coveted prize: a custom 2025 Volkswagen ID. Buzz electric bus that the Jonas Brothers have brought along for their 20th anniversary tour.   “Ten years ago, we hit the road with a goal to change what it means to live with diabetes. Since then, Beyond Type 1 has grown into the world's largest digital diabetes community, offering the tools, education, and peer support needed to not only survive but thrive with diabetes,” Jonas, who co-founded Beyond Type 1 (a nonprofit that advocates for those living with diabetes), says in a statement.     “We've challenged stigma, built community, provided life-saving resources, and collectively driven global innovation toward prevention and cure. This milestone is a moment to rally even more support for our mission, and partnering with Alltroo helps us do that in a powerful, engaging way.”   Related Stories Nick Jonas on Managing His Diabetes: 'The Mental and Emotional Health Aspect Is Really Important' nick jonas Nick Jonas Says He Was Diagnosed with Diabetes After Joe Told Their Parents: 'Something's Really Wrong' Joe Jonas and Nick Jonas attend the amfAR Cannes Gala 30th edition at Hotel du Cap-Eden-Roc on May 23, 2024 For Rudolph, the campaign is about "celebrating Beyond Type 1's incredible work over the past decade, and standing behind their vision of a world where everyone with diabetes — or at risk of it — has access to the knowledge, care and support needed for early diagnosis and lifelong health."   While the rally is live on Alltroo.com, fans can also scan QR codes available at all 36 Jonas Brothers concert stops to enter for a chance to win the electric bus. (A winner will be selected on November 14, which is World Diabetes Day.)   Jonas, 32, has long been open about his Type 1 diabetes diagnosis at 13 years old. "I had this kind of wrench thrown into things when I was diagnosed and it took a while to figure out how to count carbs to properly dose for insulin and what things would affect me in different ways," he previously told PEOPLE.   "When I was first diagnosed, I was sitting in the hospital and was scared to death, honestly, while I was learning about how to manage this new thing I was dealing with," Jonas recalled. "It would have been amazing to have someone to look at at that time to say, oh, this is a person living with it and they're following their dreams. They're doing what they want to do with their lives and not letting it slow them down."           https://people.com/nick-jonas-kyle-rudolph-launch-fan-rally-diabetes-awareness-11788684

Dr. Joseph Kanter, ASTHO CEO, Dr. Susan Kansagra, ASTHO Chief Medical Officer, Dr. Scott Harris, ASTHO President and State Health Officer for the Alabama Department of Public Health, Dr. Ayanna Bennett, Director of the District of Columbia Department of Health, and Dr. Manisha Juthani, ASTHO President-Elect and Commissioner for the Connecticut Department of Public Health, held a deskside briefing on the preparations for the upcoming respiratory virus season; Ericka McGowan, Senior Director of Emerging Infectious Disease at ASTHO, explains the importance of case investigation and contact tracing, and how ASTHO's Foundations in CICT course can help prepare public health providers; a new ASTHO brief breaks down succession planning to help public health departments develop strategies to address workforce challenges; and ASTHO will hold the first webinar of a three-part series on Thursday, September 4th, to explore building a future-ready public health workforce through succession planning.  ASTHO Blog: Strengthening Case Investigation and Contact Tracing Skills: Q&A with Ericka McGowan ASTHO Brief: Demystifying Succession Planning ASTHO Webinar: Succession Planning Part 1 of 3: Building the Case for Succession Planning  

In this episode, Dr. Tracy Beth Hoeg discusses the implications of SSRIs during pregnancy, the role of serotonin in fetal development, and the importance of transparency in FDA communications. The conversation also touches on the hormone therapy debate, the issue of over-medication in society, and the need for a focus on root causes in treatment approaches. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.com Watch The Tudor Dixon Podcast on RumbleSee omnystudio.com/listener for privacy information.

Public health is invisible when it works and only noticed when it fails. In this episode, Dr. Howard Koh reflects on the chronic underfunding, political challenges, and cultural barriers weakening America's public health system, drawing from his leadership experience during crises like 9/11, anthrax, H1N1, and the ACA rollout. He underscores the undervaluing of prevention and the difficulty of making invisible successes visible and frames public health as a spiritual calling rooted in meaning and service. Tune in and learn how we can reignite the public health torch and carry it forward, together! Learn more about your ad choices. Visit megaphone.fm/adchoices

Did you know that the food served and sold in prisons and jails contributes to poor mental and physical health? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Daniel Rosen, MA, Co-founder of the Coalition for Carceral Nutrition and Public Health Fellow at the Bard Prison Initiative. Rosen will discuss food and eating conditions in prison and jails, and the food industry that profits from the exploitation of those who are incarcerated. Rosen describes food in prison as “dietary malpractice,” and describes his personal food experiences while being incarcerated. A TEDx Talk by Lucy Vincent is discussed: Could Healthier Food Solve the Prison Crisis: https://www.youtube.com/watch?v=cfItENpMSr8 and Rosen's presentation for the Center for Science in the Public Interest is mentioned: : https://www.youtube.com/watch?v=IlfRNK0R37MRelated Websites: www.carceralnutrition.org

Under the new presidential administration, U.S. public health policy is shifting — particularly in areas like vaccinations, environmental health, and federal oversight. Mark Nathaniel Mead, MSc, a trained epidemiologist and public health research scientist, joins the podcast to explore the evolving landscape of the Department of Health and Human Services (HHS) and what it means for Americans. In this episode, you'll learn: ·       Key takeaways from the recent Senate hearing on science and federal health agencies. ·       How COVID-19 narratives and vaccine information have been suppressed. ·       Potential benefits of revising vaccine schedules for children. ·       Why virus variants may “outsmart” current vaccination strategies. Mark has contributed to publications like Natural Health, Utne Reader, and Integrative Cancer Therapies, and continues to research and publish on vaccine efficacy and safety. Follow Mark online and stay updated on his work via LinkedIn. Keep up with M. Nathaniel Mead socials here: X : https://x.com/SelfHealingOptn  YouTube: https://www.youtube.com/@marknathanielmead595  Episode also available on Apple Podcasts: https://apple.co/38oMlMr

In Episode 31, join host Ellina Yin and the team behind the Silicon Valley Pain Index (SVPI) for a deep dive into this year's report. The Annual Silicon Valley Pain Index features new data that highlights the region's persistent inequalities. The SVPI was originally inspired by Professor Bill Quigley's Katrina Pain Index following the devastating 2005 hurricane and later by 2020 Black Lives Matter national protests in the wake of the police murders of George Floyd and Breonna Taylor.Guests: Dr. Michael Dao is an Associate Professor in the Department of Kinesiology at San Jose State University and currently serves as the Associate Chair in the Department of Kinesiology and is the current Director of the SJSU Human Rights Institute.Dr. Anji Buckner-Capone is an Associate Professor, Public Health and Recreation, College of Health and Human Sciences and practitioner of community health promotion with expertise in program planning and evaluation, health education, and advocacy.Ruth Melton is a fourth year at San Jose State University, majoring in Communication Studies. She was a student assistant and co-author for the 2025 Silicon Valley Pain Index report released this month. Her interest in working with families and education comes from her non-profit involvement over the years.Briyana Costa holds a Bachelor of Science in Public Health and is currently pursuing her Master of Public Health (MPH), with a concentration in Community Health Education at San José State University.⁠Only in San José⁠ is a civic education podcast series dedicated to demystifying and democratizing the process of local government and civic participation in the City of San José.About Us ⁠| Join Patreon | One Time Donation | Volunteer Episode Resources:SJSU Silicon Valley Pain Index: https://www.sjsu.edu/hri/policy-projects/svpi/index.phpHuman Rights Institute: https://www.sjsu.edu/hri/about/index.phpSupport the Human Rights Institute with a DonationContact Person: Dr. Michael Dao michael.dao@sjsu.edu SB33 (Dave Cortese) guaranteed income for unhoused high school seniorsSB685 (Dave Cortese) pilot program covering full cost of college attendance (at select universities) for unhoused youthAB3229 (Alex Lee) pilot program to increase fruit and vegetable consumption among CalFresh recipientsMusic: Spunker by Blue Dot Sessions (https://app.sessions.blue/browse/track/271482) Creative Commons License Attribution - Noncommercial 4.0 International (CC BY-NC 4.0)*Copyright Disclaimer under Section 107 of the Copyright Act of 1976: Allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing.

Heather Tanana (Diné), a law professor at the University of Denver and associate faculty member with the Center for Indigenous Health at Johns Hopkins University School of Public Health, joins host Farina King to discuss her chapter in COVID-19 in Indian Country: Native American Memories and Experiences of the Pandemic. Her chapter, “The Intersection of the Law and Health: Water (In)security in Indian Country,” asserts that access to clean water is essential for health, culture, and community well-being, yet nearly half of Native American homes lack safe drinking water or basic sanitation compared to less than 1% nationwide. This episode examines the ongoing crisis of tribal water insecurity and the work still needed to close the gap.Resources:tribalcleanwater.org is a website that contains a lot of resources, including some reports such as "Universal Access to Clean Water for Tribal Communities"In the episode, Heather makes a reference to this grassroots and community organization: https://tonizhoniani.org/"Water Is Life: Law, Systemic Racism, and Water Security in Indian Country," an article by Heather Tanana, Julie Combs, and Alia Hoss: https://www.liebertpub.com/doi/full/10.1089/hs.2021.0034 "Abandoned Mines, Abandoned Treaties: The Federal Government's Failure to Remediate Abandoned Uranium Mines on the Navajo Nation," an article by Nadine Padilla: https://lawreview.colorado.edu/print/volume-96/abandoned-mines-abandoned-treaties-the-federal-governments-failure-to-remediate-abandoned-uranium-mines-on-the-navajo-nation-nadine-padilla/Heather Tanana, "The Intersection of the Law and Health: Water (In)security in Indian Country," in COVID-19 in Indian Country: Native American Memories and Experiences of the Pandemic, eds. Farina King and Wade Davies (Palgrave Macmillan, 2024).

Dawn Shanafelt, Director of the Division of Maternal and Infant Health and Title V Maternal Child Health Director for the State of Michigan, shares the policies and program that helped the state record its lowest infant mortality rate on record; Dulce Mendoza, Senior Analyst of Island Support at ASTHO, explains how a new learning series can help prepare public health professionals to engage with U.S. territories and freely associated states; applications are now open for ASTHO's Developing Executive Leaders in Public Health program, a ten-month intensive leadership development full of workshops, coaching, and networking opportunities; and a new ASTHO resource breaks down document management systems to help public health departments determine the best fit.  State of Michigan: Michigan records lowest rate of infant mortality in its history; continues focus on resources to keep moms, babies healthy ASTHO Learning Series: LMS Module: Exploring Key Insights of U.S. Territories and Freely Associated States ASTHO Webpage: Leadership Development  ASTHO Web Page: Document Management System  

In this two-part interview, Dr. Peter Thorne, University of Iowa Distinguished Chair and Professor of Occupational and Environmental Health and a leading expert in toxicology, provides an in-depth overview of how the federal government regulates chemicals in food, water, and air. Key points: • The EPA and FDA are science-based organizations that interpret laws passed by Congress and apply the best available science to make regulatory decisions aimed at protecting human health and the environment. • The EPA's Science Advisory Board provides independent, non-partisan oversight to ensure the agency's decisions are grounded in scientific evidence. • Chemical regulations are dynamic, with compounds like Red Dye No. 3 and inorganic arsenic being re-evaluated as new scientific data emerges. • The precautionary principle guides regulators to err on the side of safety when the evidence suggests a chemical may pose health risks, even in the absence of definitive human studies. • Replacing problematic chemicals with safer alternatives can facilitate regulatory action, though the availability of substitutes should not be the primary driver of these decisions. • Persistent organic pollutants like PCBs and PFAS pose complex public health challenges due to their ubiquity and long-lasting environmental presence, underscoring the need for continued research and policy responses. A transcript of this episode will be available soon. Have a question for our podcast crew or an idea for an episode? You can email them at CPH-GradAmbassador@uiowa.edu You can also support Plugged in to Public Health by sharing this episode and others with your friends, colleagues, and social networks. #publichealth #environmentalhealth #toxicology #climatechange

"Burnout and trauma are not mental illnesses. They live in your physiology. They live in your biology. They live very specifically in your nervous system,” Dr. Rola Hallam says with a conviction rooted in her own successful journey to overcome the effects of chronic stress she accumulated during many years on the frontlines of humanitarian crises in Syria and other conflict zones. Out of concern for the multitudes of health professionals who, like herself, spend years carrying the weight of their traumatic experiences without seeking help, or who pursue ineffective remedies for relieving it, Dr. Rola -- as she's known – has shifted her focus to being a trauma and burnout coach. Among her offerings is Beyond Burnout, a twelve-week program that includes multimedia content as well as live coaching and teaching about developing nervous system awareness and regulation. “Most wellness initiatives fail because they're not rewiring the nervous system to come out of survival mode and back into what is called the ventral-vagal state, which is our state of social connection and of healing and repair.” She also stresses that healing is not an individual pursuit, especially for providers who work in a relational field, and teaches about the benefits of borrowing from a colleagues' state of calm and offering them the same. Don't miss this insightful and giving conversation with host Lindsey Smith that covers Dr. Rola's wrenching experiences providing care in desperate conditions, the critically important distinction between empathy and compassion, and how empowering frontline workers to heal their trauma can uplift individuals and empower entire communities. Mentioned in this episode:Dr. Rola CoachingBeyond Burnout AssessmentCanDo - Humanitarian Aid If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

On June 25, 2025, B&C, along with the Environmental Law Institute and the George Washington University Milken Institute of Public Health, sponsored an all-day virtual conference, TSCA Reform -- Nine Years Later. The conference was hugely successful and almost 1,000 people registered for it. The quality of the discussion, the caliber of the participants, and the timeliness of the content inspired us to re-broadcast the discussion to our podcast audience. This panel discusses the U.S. Environmental Protection Agency's (EPA) authority under Toxic Substances Control Act (TSCA) Section 6 to manage chemical risks that EPA has determined to be unreasonable and the risk management options EPA considers to manage those risks. Panelists address how EPA manages workplace risks, enforcement mechanisms for risk management restrictions, whether EPA's risk management rulemakings are over or under addressing risks deemed unreasonable, and the legal challenges underway for all five risk management rules. ALL MATERIALS IN THIS PODCAST ARE PROVIDED SOLELY FOR INFORMATIONAL  AND ENTERTAINMENT PURPOSES. THE MATERIALS ARE NOT INTENDED TO CONSTITUTE LEGAL ADVICE OR THE PROVISION OF LEGAL SERVICES. ALL LEGAL QUESTIONS SHOULD BE ANSWERED DIRECTLY BY A LICENSED ATTORNEY PRACTICING IN THE APPLICABLE AREA OF LAW. ©2025 Bergeson & Campbell, P.C.  All Rights Reserved

For most people, asthma is a disease you manage with inhalers, pills, and a prayer that the ER isn't your next stop. But new research is upending that view and changing everything we know about managing the condition.  The big shift? Medication alone might be the least effective way to manage this chronic condition.  Asthma is, after all, inflammatory by nature, but the lifestyle choices that fuel or fight inflammation are often ignored in traditional care plans.  What if the real triggers aren't just pollen or pets, but processed food, poor sleep, and unchecked anxiety? And what if healing asthma requires more than bronchodilators, like learning how to breathe all over again?  So what does a truly modern, whole-person approach to asthma look like?  In this episode, I'm joined by Dr. Atoosa Kourosh, an Asthma, Allergy & Immunology consultant physician and integrative medicine leader who's spent two decades treating asthma from every angle, not just the pharmaceutical one.  We dive into what the latest science says about lifestyle as medicine, and how breathwork, nutrition, exercise, and gut health are changing the game for asthma patients everywhere. Things You'll Learn In This Episode  Why your exhale matters more than your inhale Most asthma patients struggle more with getting air out than in. What do breathing techniques like Buteyko and Papworth do that traditional deep breathing doesn't, and how can they rewire the lungs for better control? Can a Mediterranean diet reduce airway inflammation? Forget calorie counting. How do whole foods, fiber, and fermented veggies change your lung health through your gut? How obesity triggers two kinds of asthma dysfunction What's the double whammy effect of body fat on asthmatic lungs? The cortisol-microbiome-asthma triangle What happens to your microbiome when you miss a night of sleep?   Guest Bio Dr. Atoosa Kourosh, MD, MPH, RYT, is a physician, board-certified in Pediatrics, Asthma, Allergy & Immunology, and Public Health. She's also a patient health advocate. Dr. Kourosh combines treatment modalities from cutting-edge and mainstream medicine with the best of functional and integrative medicine therapies and traditional philosophies to treat the whole person in their environment. She is chair of the American College of Allergy, Asthma, and Immunology Integrative Medicine Committee and is an internationally renowned expert on holistic and integrative health. Visit https://www.doctoratoosa.com/ to learn more.    About Your Host Hosted by Dr. Deepa Grandon, MD, MBA, a triple board-certified physician with over 23 years of experience working as a Physician Consultant for influential organizations worldwide. Dr. Grandon is the founder of Transformational Life Consulting (TLC) and an outspoken faith-based leader in evidence-based lifestyle medicine.   Resources Feeling stuck and want guidance on how to transform your spiritual, mental and physical well being? Get access to Dr Deepa's 6 Pillars of Health video! Visit drdeepa-tlc.org to subscribe and watch the video for free. ‌ Work with Me Ready to explore a personalized wellness journey with Dr. Deepa? Visit drdeepa-tlc.org and click on “Work with Me” to schedule a free intake call. Together, we'll see if this exclusive program aligns with your needs!  Want to receive a devotional every week From Dr. Deepa? Devotionals are dedicated to providing you with a moment of reflection, inspiration, and spiritual growth each week, delivered right to your inbox. Visit https://www.drdeepa-tlc.org/devotional-opt-in to subscribe for free. Ready to deepen your understanding of trauma and kick start your healing journey? Explore a range of online and onsite courses designed to equip you with practical and affordable tools. From counselors, ministry leaders, and educators to couples, parents and individuals seeking help for themselves, there's a powerful course for everyone. Browse all the courses now to start your journey.   ​​TLC is presenting this podcast as a form of information sharing only. It is not medical advice or intended to replace the judgment of a licensed physician. TLC is not responsible for any claims related to procedures, professionals, products, or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services, or methods that might be referenced. Check out this episode on our website, Apple Podcasts, or Spotify, and don't forget to leave a review if you like what you heard. Your review feeds the algorithm so our show reaches more people. Thank you!

Dr. Andriy Klepikov, the founder and executive director of the Alliance for Public Health (Ukraine), reflects on the Alliance's remarkable evolution over the past 25 years into a major Ukrainian—and regional—non-governmental force in HIV, TB, and harm reduction programs. Foundational to its early success was the exemplary partnership with the Global Fund and PEPFAR. Ukraine, in the midst of war, cannot at present soon transition to self-reliance. In the past three and a half years of war following the Russian invasion, the Alliance has become a provider of mass emergency humanitarian relief to the most vulnerable in Ukraine. It now serves five times the numbers it served before the war. Recovery will draw on telemedicine and mobile clinics, and prioritize mental health, war veterans who are blinded, have lost limbs, and struggle with long-term trauma. The United States remains indispensable to Ukraine's future—for peace and social justice.  

Donald Trump once declared mRNA vaccines a medical miracle, now his health Secretary is taking an axe to them.Robert F Kennedy Junior doesn't believe in the science behind the vaccines that were deployed to save lives as Covid spread around the world and he's cut nearly half a billion dollars in research funding.Today, professor of public health Julie Leask on what Kennedy's anti-vaccine stance means for global health. Featured: Julie Leask, social scientist and professor in the School of Public Health at the University of Sydney

 Much of the progress Oregon has made in expanding health care access is at risk as a result of the federal budget reconciliation bill enacted by Congress.  In this episode of Policy for the People, we discuss the past, present and future of Oregon's system of health care, including the threats posed by the federal budget reconciliation bill. Our guest is Dr. Bruce Goldberg. Bruce is a professor at the OHSU-PSU School of Public Health and a nationally recognized health policy expert. 

 As cigarette use resurges, Nicholas Florko, a staff writer at The Atlantic who covers how business and policy affect our well-being, looks at the question of nicotine's safety on its own and in e-cigarettes, vapes and Zyn. "What's So Bad About Nicotine?" (The Atlantic, August 1, 2025)

About this episode: Since 2010, the nonprofit ChopChop Family has published magazines, cookbooks, and other tools to help pediatricians and nutrition educators inform families about the positive health outcomes of cooking nutritious foods. But deep cuts to SNAP-Ed, the federally-funded nutrition education program, are placing programs like ChopChop Family in limbo. In this episode: ChopChop Family founder and president Sally Sampson explains how the rapid rollback of SNAP-Ed is crippling nutrition education. Guest: Sally Sampson is a cookbook author and the founder and president of ChopChop Family, a nonprofit publisher of cooking magazines, cookbooks, digital content, cooking curricula, and learning decks for children and families. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Budget cuts knock down a ‘pillar of public health,' ending nutrition education—STAT ChopChop Podcast—Apple Podcasts ChopChop Family Newsletter—Substack Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

About this episode: The Department of Health and Human Services has cancelled nearly $500 million in funding for the development of mRNA vaccines, including for vaccines against potential new pandemic threats. In this episode: Professor Bill Moss delves into the misinformation surrounding mRNA vaccines, explains their potential to treat diseases like cancer and HIV, and warns of the national security threats posed by cuts to development. Guest: Dr. Bill Moss, MPH, is an infectious disease specialist and the executive director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs. Show links and related content: Johns Hopkins expert speaks on ripple effect of federal cuts to mRNA vaccine contracts—WBAL-TV 11 How Cuts to mRNA Vaccine Development Will Set the U.S. Back—Johns Hopkins Bloomberg School of Public Health What to know about mRNA vaccines as Trump admin pulls funding—Axios For mRNA Vaccines, COVID-19 Is Just the Beginning—Johns Hopkins Bloomberg School of Public Health Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com

Dr. Hoffman continues his conversation with Dr. Ramona Wallace.

For many, integrative medicine has become an unattainable luxury, and healthy diet and lifestyle the prerogative of the privileged. Today's guest, Dr. Ramona Wallace, is attempting to change that. Trained conventionally as a DO, she undertook additional training and certification via the Institute for Functional Medicine to broaden her clinical skills. She practices primary care in an underserved community in Kalamazoo, Michigan, where she incorporates diet and lifestyle recommendations to address her patients' chronic conditions. Careful nutritional assessment has revealed that many of her patients, while overtly overweight, are decidedly malnourished. She has documented a wide range of deficiencies—of B vitamins, vitamins A, C, and D, critical minerals like zinc and magnesium, even full-blown scurvy. These are precisely the patients who are most likely to benefit from nutritional support. Discovering obstacles to compliance is a key element to effect their health transformations. Dr. Wallace believes that individualized care is the key to reversing long-standing health conditions. She mentors medical students in the first-of-its-kind Functional Medicine program at a medical school. She has also co-authored a landmark paper arguing for wellness self-care by doctors, to stave off burnout and to help them be better role models for patients.

Dr. Michelle Morse, Acting Commissioner and Chief Medical Officer for the New York City Health Department, explains how the city's new video series aims to help educate communities about the impact of Long COVID; Dr. Nirav Shah, ASTHO Alum and former Principal Deputy Director at the CDC, discusses the focus of this year's Executive Leadership Forum, and what he hopes to teach future public health professionals in his new role as a professor at Colby College; Emman Parian, Immunization Program Manager at the Commonwealth Healthcare Corporation of the Northern Mariana Islands, shares what he learned from the Building Capacity to Advance Health certificate program; ASTHO will host the third webinar session of the Accelerate series on Thursday, August 14th, about accountability, performance, and feedback; and a new ASTHO resource helps public health teams communicate effectively about infectious disease preparedness.  New York City Health Department: Facts vs Fiction: What is Long COVID? A discussion with Dr. Michelle Morse and Matt McGorry New York City Health Department: Living with Long COVID: Matt McGorry's story New York City Health Department: The risks and realities of Long COVID: A discussion with Dr. Michelle Morse and Matt McGorry  ASTHO Web Page: Building Capacity to Advance Health Certificate Program Emman Parian LinkedIn ASTHO Webinar: Ignite, Accelerate, and Activate: Series 2, Session 3: Accountability, Performance, Feedback ASTHO Web Page: Communicating About Infectious Disease Preparedness  

This week on Health Matters our host, Courtney Allison, talks to rehabilitation medicine specialist, Dr. Asad Siddiqi about what is happening in our bodies when we cold plunge, the health benefits of hopping into frigid water, and some potential risks to keep in mind. __Asad Siddiqi, DO, CAQSM is a sports medicine physician and chief of the Department of Rehabilitation Medicine at NewYork-Presbyterian Brooklyn Methodist Hospital. He is also an assistant professor of clinical rehabilitation medicine at Weill Cornell Medicine with board certification in rehabilitation medicine and primary care sports medicine. He specializes in the comprehensive management of acute and chronic sports injuries, concussion care, and injury prevention, and he serves as team physician for the City College of New York, the United Nations International School, and a number of youth sport and performing arts organizations. He was a member of the traveling medical staff for Team USA at the 2015 World Karate Federation Junior and Cadet Under-21 Championships in Jakarta, Indonesia. He also held a weekly performing arts medicine clinic at the South Carolina Governor's School for Arts and Humanities, focused on prevention and management of injuries in the budding visual and performing artist. Additionally, he attained certification as a regional classifier for the National Wheelchair Basketball Association. He maintains active membership in several professional societies including the American Medical Society for Sports Medicine and the Association of Academic Physiatrists, which allows him to stay on the cutting edge of evidence-based treatment principles. He is an advocate for healthy lifestyles and physical activity promotion, and is a firm believer that everybody is an athlete. __Health Matters was created to share the remarkable stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive healthcare delivery networks.In keeping with NewYork-Presbyterian's long history of medical excellence, Health Matters features the latest news and insights from our world-class physicians, nurses, and experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our academic partners Columbia University Medical Center and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

The Kids Online Safety Act has one giant problem. There are genuine concerns regarding kids and teens interacting with the internet, and we should approach this like any other public health problem. What we shouldn't do is have another moral panic and allow these massive platforms to control even more of our lives. -o-www.everythingispublichealth.comBluesky Social: @everythingisPHMastodon: @everythingispublichealth Email: EverythingIsPublicHealth@gmail.com  Photo Credit: Photo by Ludovic Toinel on UnsplashSupport the show

Michael Osterholm, PhD, MPH, founding director of the Center for Infectious Disease Research and Policy (CIDRAP), member of the Vaccine Integrity Project, and the author, with Mark Olshaker, of the forthcoming book, The Big One: How We Must Prepare for Future Deadly Pandemics (Little, Brown Spark, 2025), talks about RFK Jr.'s cuts to mRNA vaccine development and what they mean for public health and science, plus other vaccine-related news.

As the lead wreaks havoc on Cooper's development, Shannon searches for answers. Desperate to get a handle on what was happening to her son, she grabs onto a lifeboat - nursing school. Andy tries to piece together the past to make sense of the present.LEAD how this story ends is up to us is a true story written and produced by Shannon Burkett. Co-produced by Jenny Maguire. Directed by Alan Taylor. Starring Merritt Wever, Alessandro Nivola, Cynthia Nixon, and Cooper BurkettEP2 features Keith Nobbs and Frank Wood. Music by Peter Salett. Sound Design by Andy Kris. Recording Engineer Krissopher Chevannes. Casting by Alaine Alldaffer and Lisa Donadio.For corresponding visuals and more information on how to protect children from lead exposure please go to https://endleadpoisoning.org.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com

Dr. Huntley sits down with Abby Tighe, a former CDC public health advisor and co-founder of the Fired by Fighting coalition. Together, they share an insider's look at the nationwide impact of the 2025 mass firing of thousands of CDC and HHS professionals and the dangerous dismantling of America's public health infrastructure. They also highlight how a grassroots movement is fighting back. Abby details her unexpected professional journey, her passion for equitable and rural health, and how losing her position became a rallying point for collective advocacy and transparency. Through her story and the birth of Fired by Fighting, listeners are called to action: Public health needs everyone, whether you're an expert, advocate, or everyday citizen. If you care about the health of your community, want to understand the real impact of policy changes, or are curious how you can help rebuild and protect America's public health future, this episode is for you. Resources ▶️ Join the PHEC Podcast Community ▶️ Visit the PHEC Podcast Show Notes ▶️ DrCHHuntley, Public Health & Epidemiology Consulting

Dr. James Lewis, Health Officer for the Snohomish County Health Department in Washington State, explains how data can help quicken healthcare-assosciated infection response; Lyla Hunt, Deputy Director of Public Health and Education at the New York State Office of Cannabis Management, tells us about the recent Cannabis Regulator Association stakeholder meeting; a new ASTHO resource can help your department reprioritize Black maternal health; and ASTHO's INSPIRE hub also has resources for Wastewater Surveillance. CORHA Web Page Shonomish County Health Department Web Page Cannabis Regulators Association Web Page ASTHO Blog Article: Reprioritizing Black Maternal Health ASTHO Web Page: INSPIRE ASTHO Web Page: Advancing Wastewater Surveillance for Public Health Impact  

In this episode of The Healthy Project Podcast, host Corey Dion Lewis talks with Pamela Oren-Artzi, COO and co-founder of GRIN, a digital oral health platform reimagining how care is delivered for underserved communities. Pam shares her journey from technology leader to health innovator, the challenges of addressing oral care deserts, and how GRIN's accessible, affordable tools are transforming the way providers reach patients—no broadband required.We explore why oral health must be recognized as a core social driver of health, the connection between oral disease and chronic conditions like heart disease and diabetes, and the ripple effects that poor access to dental care can have on individuals, families, and the economy. Pam also offers valuable insights for health tech innovators on how to build equity into products from the ground up.

In this conversation, Omari Richins, MPH discusses the challenges faced by public health professionals, particularly during times of uncertainty and transition. He emphasizes the importance of redefining success, building community, and maintaining one's identity and purpose in the field. He offers practical advice on how to navigate career changes, cope with burnout, and find fulfillment in public health work, encouraging listeners to embrace their journey and seek support from others.Join our Patreon (TPHM Cousins)

 We're taking a breather this August as we work on bringing you more great episodes of the ATS Breathe Easy podcast. But we're not going off the air - instead, we're bringing back some of our best episodes of the last season. See you in September for season two! Erika Moseson, MD, of the Air Health Our Heath podcast hosts this week's episode with guest Daniel Croft, MPH, ATSF. Dr. Croft is associate professor in the Department of Environmental Medicine at the University of Rochester Medical Center. On this episode we share insights from the Climate Change and Respiratory Health: Opportunities to Contribute to Environmental Justice: An Official American Thoracic Society Workshop Report. For additional discussion on environmental health, please also view our recent Breathe Easy episode 12 “EPA Rollbacks Spell Grave Impacts on Public Health” for an up-to-date discussion of current national changes related to health care, environmental health and environmental justice. 

This conversation explores the war on science, the misdirection of the MAHA movement, and what's happening to public health while everyone argues about food dyes. We discuss how a $1.1 trillion healthcare cut happened under the radar, why "seed oils" didn't exist until TikTok invented them, and Jessica's systemic solutions for actually making America healthy. Additionally, she explains how health misinformation has become a profitable fear machine. Jessica brings compassionate clarity to the current health policy landscape. Enjoy! Show notes + MORE Watch on YouTube Newsletter Sign-Up   Today's Sponsors:  Go Brewing: Use the code Rich Roll for 15% OFF

A British parliamentarian spoke about the dangers of abandoning western and Christian values, but no one showed up to listen. ______________ Find more information about the Truth Rising documentary at truthrising.com/colson. 

About this episode: As the United States grows more polarized along regional, political, and ideological lines, it is critical to resolve conflict civilly—particularly when it comes to pressing public health concerns that implicate all of us. In this episode: Peace building experts David Addiss and John Paul Lederach draw on their careers in conflict resolution and public health to share strategies for building relationships, restoring trustworthiness, and fostering solutions-oriented conversations to bridge ideological gaps. Guest: Dr. David Addiss, MPH, is a public health doctor whose career has involved migrant health, mountain medicine, neglected tropical diseases, research, philanthropy, and global health. He is the Director of the Focus Area for Compassion and Ethics at the Task Force for Global Health. John Paul Lederach, PhD, is Professor Emeritus at the University of Notre Dame and a Senior Fellow with Humanity United. He is widely known for the development of culturally-based approaches to conflict transformation and the design and implementation of integrative and strategic approaches to peace building. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: A Recipe for Cooling Down American Politics—Washington Post Facing Down a Civil War—www.johnpaullederach.com Here To Understand: How Braver Angels Is Orchestrating Tough Public Health Conversations—Public Health On Call (June 2025) Peacebuilding to Help Mend A Broken World—Public Health On Call (December 2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Three simple questions plague every American seeking healthcare: Where should I go? When can I be seen? And how much will it cost me? Despite seeming basic, these questions have remained largely unanswerable—until now.In this episode, we explore how Heather Fernandez, co-founder and CEO of Solv, is building the infrastructure behind same-day care for 210 million Americans. We discuss how AI is finally cracking the code on price transparency and why workflow complexity can be a competitive moat in healthcare.We cover:

Carolyn Mullen, ASTHO Senior Vice President of Government Affairs and Public Relations, shares more of her story in this installment of Get To Know ASTHO; Juliane Walker, Public Health Program Specialist at the Wichita State University Community Engagement Institute, discusses the Public Health Employee Well-Being Assessment Guide; an article published in the Journal of Public Health Management and Practice takes a deeper look at using AI to expedite content analysis of real-world public health documents; and Dr. Susan Kansagra, ASTHO Chief Medical Officer, helped author a blog article that provides insights from several executive leadership coaching events. ASTHO Web Page: Federal Government Affairs Kansas Health Institute Web Page: Public Health Employee Well-Being Assessment Guide Journal of Public Health Management and Practice Web Page: Content Analysis of Social Determinants of Health Accelerator Plans Using Artificial Intelligence – A Use Case for Public Health Practitioners ASTHO Blog Article: Insights from Executive Leadership Coaching for Public Health and Community Leaders  

Episode 4696: The Mainstream's Destruction Of Public Health

Rejecting Christianity will mean losing those cultural goods that depend on Christian values, such as freedom of speech and religion.  ____________ Give any gift to the Colson Center this month and recieve digital access to the 2025 Colson Center National Conference at colsoncenter.org/august. 

In this bonus episode of Breakpoint, John Stonestreet has a conversation with Gabe Lyons, Andrew Walker, and Ryan Anderson. They discuss what can we learn by looking back over the last several decades of the Church's involvement in culture and what it means to embrace and lose our public morality.